Unasyn and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Unasyn (ampicillin sodium; sulbactam sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Indocin, and have Premature labor.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Unasyn. It is created by eHealthMe based on reports of 4,454 people who have side effects when taking Unasyn from the FDA, and is updated regularly.

What is Unasyn?

Unasyn has active ingredients of ampicillin sodium; sulbactam sodium. eHealthMe is studying from 4,474 Unasyn users. Check the latest studies of Unasyn.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,194 drugs and 1,649 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 13, 2026

4,454 people reported to have side effects when taking Unasyn.
Among them, 14 people (0.31%) have Bleeding disorders.

Among these 14 people:

How long have people been on Unasyn when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Unasyn? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Bleeding disorders when taking Unasyn? *

What are other drugs people take besides Unasyn? *

What are other side effects people have besides Bleeding disorders? *

Urine Output - Decreased: 7 people, 50.00%
Premature Baby: 6 people, 42.86%
Peritoneal Haemorrhage (peritoneal bleeding): 6 people, 42.86%
Complications Of Maternal Exposure To Therapeutic Drugs: 5 people, 35.71%
Hypotension (abnormally low blood pressure): 5 people, 35.71%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 35.71%
Foetal Growth Retardation (a baby in the womb fails to grow at the expected rate during the pregnancy): 5 people, 35.71%
Apgar Score Low: 4 people, 28.57%
Stress And Anxiety: 4 people, 28.57%
Breech Delivery (delivery of an infant whose feet or buttocks appear first): 4 people, 28.57%

What are the existing conditions these people have? *

Premature Labor: 6 people, 42.86%
Fever: 4 people, 28.57%
Hypotension (abnormally low blood pressure): 2 people, 14.29%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Unasyn and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Unasyn:

Unasyn (4,474 reports)

Bleeding disorders treatments and more:

Bleeding disorders (24,450 reports)

How severe was Bleeding disorders and when was it recovered:

Bleeding disorders in Unasyn

Expand to all the drugs that have ingredients of ampicillin sodium; sulbactam sodium:

Bleeding disorders and drugs with ingredients of ampicillin sodium; sulbactam sodium (33 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Unasyn:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,194 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,649 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ampicillin sodium; sulbactam sodium (the active ingredients of Unasyn) and Unasyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.